Global Plan to end TB 2016-2020
World's largest Science, Technology & Medicine Open Access book publisher
Chapter 7 from the book People's Movements in the 21st Century - Risks, Challenges and Benefits
Clinical Medicine
JCI Insight. 2017;2(7):e91963.
AIDS Behav (2017) 21:S23–S33 DOI 10.1007/s10461-016-1670-9
This assessment seeks to better understand what types of legal migration pathways and other protection services Iraqi refugees and other migrants are aware of and attempt to access at different points during their migration journey. Furthermore, it highlights when, where and why Iraqi refugees and o...ther migrants fail to access protection services.
more
With the recent advances in medicine, the survival rate of clients with
severe burns has improved. This has resulted in greater demand for rehabilitation services. One of the major goals for rehabilitation programmes is to restore these clients to their pre-trauma activity levels. However, there is... not much research on the subject.
more
Training materials for healthcare workers
UNAIDS 2017 / Reference
Generating evidence for policy and action on HIV and social protection
Technical Update
HIV Treatment
July 2017
A review of available evidence (2016).
28-29 June 2016; Geneva, Switzerland
The END TB strategy.
National Tuberculosis and Leprosy Control Program
Guidelines for treatment of drug-susceptible tuberculosis and patient care
2017 update
Lymphatic filariasis is a vector-borne neglected tropical disease that causes damage of the lymphatic system and can lead to lymphoedema (elephantiasis) and hydrocele in infected individuals. The global baseline estimate of persons affected by lymphatic filariasis is 25 million men with hydrocele an...d over 15 million people with lymphoedema. At least 36 million persons remain with these chronic disease manifestations. The disease is endemic in 72 countries. In 2016, an estimated total population of 856 million were living in areas with ongoing transmission of the causative filarial parasites and requiring mass drug administration (MDA). Lymphatic filariasis disfigures and disables, and often leads to stigmatization and poverty. Hundreds of millions of dollars are lost annually due to reduced productivity of affected patients. WHO has ranked the disease as one of the world’s leading causes of permanent and long-term disability.
more
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i...ted. Initially, due to their high prices, affordability of DAAs was limited in high-, middle- and low-
income countries alike. Now there is a divide between those countries where, because of intellectual
property barriers, prices have remained (very) high and other countries where generics are, or can be,
available at much lower prices. The result is a dual market
more